Drug company Novartis has named Klaus Moosmayer as chief ethics, risk and compliance officer, effective Dec. 1. Moosmayer will report to the CEO of Novartis in Basel, Switzerland, and serve as a member of the company’s executive committee.

His post was added to the committee in April in an effort to help the company restore its reputation, which took a hit over a recently revealed connection with President Donald Trump’s former personal lawyer.